BERKELEY, Calif.--(BUSINESS WIRE)--Aug. 9, 2006--XOMA Ltd. (NASDAQ:XOMA), a leader in the discovery and development of antibody therapeutics for cancer and immunological disorders, today announced its results for the second quarter ended June 30, 2006.
